|
|
Name: |
EcoR1 Capital LLC |
City: |
San Francisco |
State: |
CA |
Zip: |
94158 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
58 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
APLS |
Apellis Pharmaceuticals Inc |
1 |
- |
$49.86 |
$668,820,000 |
11,173,068 |
17.37% |
254,189,000 |
273,209 |
9.761 |
N/A |
|
MRTX |
Mirati Therapeutics, Inc. |
2 |
- |
$58.70 |
$434,573,000 |
7,396,979 |
11.28% |
184,173,000 |
1,648,580 |
11.051 |
Biotechnology |
|
PRTA |
Prothena Corp Plc |
3 |
- |
$20.87 |
$420,973,000 |
11,584,280 |
10.93% |
-137,969,000 |
0 |
22.437 |
N/A |
|
ARVN |
Arvinas Holding Company, Llc |
4 |
- |
$32.37 |
$276,862,000 |
6,726,491 |
7.19% |
169,489,000 |
1,259,428 |
12.641 |
N/A |
|
GLPG |
Galapagos NV - ADR |
5 |
- |
$28.76 |
$233,992,000 |
5,756,268 |
6.08% |
35,113,000 |
0 |
8.81 |
N/A |
|
ACAD |
Acadia Pharmaceuticals Inc |
6 |
- |
$16.71 |
$187,593,000 |
5,991,479 |
4.87% |
62,731,000 |
0 |
3.727 |
Biotechnology |
|
ANAB |
Anaptysbio Inc |
7 |
- |
$21.00 |
$161,100,000 |
7,521,024 |
4.18% |
26,022,000 |
0 |
23.648 |
N/A |
|
ZYME |
Zymeworks Inc |
8 |
- |
$8.26 |
$139,615,000 |
13,437,473 |
3.62% |
54,421,000 |
0 |
21.032 |
N/A |
|
TNGX |
Tango Therapeutics Ord Shs |
9 |
- |
$0.00 |
$131,974,000 |
13,330,736 |
3.43% |
33,768,000 |
4,609,100 |
15.226 |
N/A |
|
JAZZ |
Jazz Pharmaceuticals Inc |
10 |
- |
$109.27 |
$124,716,000 |
1,013,952 |
3.24% |
77,029,000 |
645,541 |
1.658 |
Biotechnology |
|
ARGX |
Argenx Se |
11 |
New |
$372.80 |
$114,508,000 |
300,997 |
2.97% |
114,508,000 |
300,997 |
0.64 |
N/A |
|
XNCR |
Xencor Inc |
12 |
- |
$19.98 |
$112,148,000 |
5,282,516 |
2.91% |
5,705,000 |
0 |
7.958 |
Biotechnology |
|
KURA |
Kura Oncology Inc |
13 |
- |
$19.65 |
$83,503,000 |
5,806,871 |
2.17% |
30,544,000 |
0 |
7.624 |
N/A |
|
SRPT |
Sarepta Therapeutics Inc |
14 |
- |
$128.77 |
$80,317,000 |
832,907 |
2.09% |
80,317,000 |
832,907 |
0.989 |
Drug Manufacturers - ... |
|
CRNX |
Crinetics Pharmaceuticals, ... |
15 |
- |
$42.12 |
$71,605,000 |
2,012,517 |
1.86% |
26,095,000 |
482,254 |
3.469 |
N/A |
|
MRSN |
Mersana Therapeutics, Inc. |
16 |
- |
$2.94 |
$44,926,000 |
19,364,688 |
1.17% |
20,333,000 |
0 |
17.277 |
N/A |
|
CNTA |
Centessa Pharmaceuticals Plc |
17 |
- |
$0.00 |
$44,725,000 |
5,618,779 |
1.16% |
8,371,000 |
0 |
6.427 |
N/A |
|
IMNM |
Immunome Inc. |
18 |
New |
$13.73 |
$41,510,000 |
3,879,415 |
1.08% |
41,510,000 |
3,879,415 |
38.678 |
N/A |
|
EWTX |
Edgewise Therapeutics, Inc. |
19 |
- |
$0.00 |
$38,216,000 |
3,493,194 |
0.99% |
18,200,000 |
0 |
5.004 |
N/A |
|
NMRA |
Neumora Therapeutics, Inc. |
20 |
- |
$9.15 |
$35,318,000 |
2,071,450 |
0.92% |
6,090,000 |
0 |
1.357 |
N/A |
|
THRD |
Third Harmonic Bio, Inc. |
21 |
- |
$10.83 |
$34,911,000 |
3,182,444 |
0.91% |
15,853,000 |
200,000 |
7.85 |
N/A |
|
VYGR |
Voyager Therapeutics, Inc. |
22 |
- |
$7.62 |
$32,507,000 |
3,851,507 |
0.84% |
2,658,000 |
0 |
10.279 |
N/A |
|
ALEC |
Alector, Inc. |
23 |
- |
$5.25 |
$32,371,000 |
4,056,548 |
0.84% |
6,085,000 |
0 |
5.119 |
N/A |
|
ORIC |
Oric Pharmaceuticals, Inc. |
24 |
- |
$0.00 |
$31,446,000 |
3,418,068 |
0.82% |
10,767,000 |
0 |
8.693 |
N/A |
|
TCRX |
Tscan Therapeutics, Inc. |
25 |
- |
$0.00 |
$29,150,000 |
5,000,000 |
0.76% |
16,350,000 |
0 |
26.853 |
N/A |
|
NUVB |
Nuvation Bio Ord Shs Class A |
26 |
- |
$10.42 |
$29,007,000 |
19,209,643 |
0.75% |
3,266,000 |
0 |
8.867 |
N/A |
|
PHVS |
Pharvaris N V Ord Shs |
27 |
New |
$0.00 |
$25,245,000 |
900,000 |
0.66% |
25,245,000 |
900,000 |
2.717 |
N/A |
|
NGNE |
Neurogene |
28 |
New |
$3.68 |
$24,639,000 |
1,271,342 |
0.64% |
24,639,000 |
1,271,342 |
3.035 |
N/A |
|
GRPH |
Graphite Bio, Inc. |
29 |
- |
$0.00 |
$22,371,000 |
8,538,446 |
0.58% |
1,196,000 |
0 |
14.701 |
N/A |
|
AVIR |
Atea Pharmaceuticals, Inc. |
30 |
- |
$0.00 |
$21,337,000 |
6,995,861 |
0.55% |
349,000 |
0 |
8.468 |
N/A |
|
OVID |
Ovid Therapeutics Inc. |
31 |
- |
$3.10 |
$19,698,000 |
6,117,400 |
0.51% |
-3,793,000 |
0 |
9.643 |
N/A |
|
AGLE |
Aeglea Biotherapeutics, Inc. |
32 |
- |
$0.60 |
$19,090,000 |
887,076 |
0.5% |
16,640,000 |
687,080 |
1.45 |
N/A |
|
VERV |
Verve Therapeutics, Inc. |
33 |
New |
$0.00 |
$17,425,000 |
1,250,000 |
0.45% |
17,425,000 |
1,250,000 |
1.881 |
N/A |
|
ITOS |
Iteos Therapeutics, Inc. |
34 |
New |
$0.00 |
$12,209,000 |
1,115,022 |
0.32% |
12,209,000 |
1,115,022 |
2.937 |
N/A |
|
GOSS |
Gossamer Bio Inc |
35 |
- |
$0.67 |
$8,391,000 |
9,195,404 |
0.22% |
733,000 |
0 |
9.733 |
N/A |
|
MORF |
Morphic Holding, Inc. |
36 |
- |
$28.07 |
$6,101,000 |
211,262 |
0.16% |
-27,810,000 |
-1,268,928 |
0.549 |
N/A |
|
PRQR |
ProQR Therapeutics N.V. |
37 |
- |
$1.94 |
$5,900,000 |
2,980,016 |
0.15% |
2,026,000 |
0 |
5.943 |
N/A |
|
ATRA |
Atara Biotherapeutics, Inc. |
38 |
New |
$0.69 |
$5,162,000 |
10,067,043 |
0.13% |
5,162,000 |
10,067,043 |
9.264 |
N/A |
|
ALGS |
Aligos Therapeutics, Inc. |
39 |
- |
$0.00 |
$4,243,000 |
6,389,468 |
0.11% |
1,294,000 |
2,441,108 |
18.24 |
N/A |
|
RVMD |
Revolution Medicines, Inc. |
40 |
- |
$35.96 |
$3,802,000 |
132,579 |
0.1% |
-150,593,000 |
-5,445,284 |
0.116 |
N/A |
|
HOOK |
Hookipa Pharma Inc. |
41 |
- |
$0.00 |
$3,722,000 |
4,595,024 |
0.1% |
891,000 |
0 |
9.031 |
N/A |
|
GBIO |
Generation Bio Co. |
42 |
- |
$0.00 |
$3,377,000 |
2,046,867 |
0.09% |
-4,381,000 |
0 |
3.445 |
N/A |
|
NGM |
Ngm Biopharmaceuticals Inc |
43 |
- |
$1.54 |
$2,049,000 |
2,385,873 |
0.05% |
-4,837,000 |
-4,049,645 |
3.457 |
N/A |
|
ALLK |
Allakos Inc. |
44 |
- |
$1.02 |
$2,044,000 |
748,900 |
0.05% |
344,000 |
0 |
0.879 |
N/A |
|
TYRA |
Tyra Biosciences, Inc. |
45 |
New |
$0.00 |
$1,898,000 |
137,014 |
0.05% |
1,898,000 |
137,014 |
0.332 |
N/A |
|
PHAT |
Phathom Pharmaceuticals, Inc. |
46 |
- |
$0.00 |
$1,812,000 |
198,480 |
0.05% |
-5,447,000 |
-501,520 |
0.582 |
N/A |
|
PMVP |
Pmv Pharmaceuticals, Inc. |
47 |
New |
$0.00 |
$1,757,000 |
566,879 |
0.05% |
1,757,000 |
566,879 |
1.042 |
N/A |
|
NUVB.WS |
Nuvation Equity Warrants Ex... |
48 |
- |
$0.00 |
$1,455,000 |
963,333 |
0.04% |
164,000 |
0 |
10.704 |
N/A |
|
SRZNW |
Surrozen Equity Warrant Exp... |
49 |
- |
$0.00 |
$627,000 |
66,665 |
0.02% |
594,000 |
0 |
0.741 |
N/A |
|
CMAXW |
Caremax Equity Warrant Exp ... |
50 |
- |
$0.00 |
$50,000 |
100,000 |
0% |
-162,000 |
0 |
0.111 |
N/A |
|
TPST |
Tempest Therapeutics, Inc |
58 |
Closed |
$1.06 |
$0 |
0 |
0% |
-284,000 |
-931,000 |
0 |
Biotechnology |
|
PRME |
Prime Medicine, Inc. |
55 |
Closed |
$4.43 |
$0 |
0 |
0% |
-5,724,000 |
-600,000 |
0 |
N/A |
|
SLRN |
Acelyrin, Inc. |
54 |
Closed |
$4.24 |
$0 |
0 |
0% |
-14,260,000 |
-1,402,201 |
0 |
N/A |
|
DCPH |
Deciphera Pharmaceuticals, ... |
53 |
Closed |
$14.65 |
$0 |
0 |
0% |
-12,631,000 |
-993,000 |
0 |
N/A |
|
PRLD |
Prelude Therapeutics Inc |
52 |
Closed |
$0.00 |
$0 |
0 |
0% |
-3,577,000 |
-1,157,452 |
0 |
N/A |
|
ALLO |
Allogene Therapeutics, Inc. |
56 |
Closed |
$0.00 |
$0 |
0 |
0% |
-14,228,000 |
-4,488,200 |
0 |
N/A |
|
RLAY |
Relay Therapeutics, Inc. |
51 |
Closed |
$6.37 |
$0 |
0 |
0% |
-35,018,000 |
-4,163,824 |
0 |
N/A |
|
SWTX |
Springworks Therapeutics, Inc. |
57 |
Closed |
$0.00 |
$0 |
0 |
0% |
-80,000,000 |
-3,460,208 |
0 |
N/A |
|